Discussing the yeast Candida albicans, biochemist Alexander Johnson describes a resident of the human gut that can turn into a fatal pathogen in the immunocompromised. Johnson, a professor of microbiology and immunology at the University of California, San Francisco, appreciates the genetic intricacies of this eukaryote that changed his views on transcriptional regulation and the evolution of molecular circuitry. In his Inaugural Article, Johnson, elected to the National Academy of Sciences in 2011, combines biochemistry, genetics, and structural biology to reveal the structure of a highly conserved protein that regulates pathogenesis in a wide variety of fungi (1) .
Science and Writing
Born in Oak Ridge, Tennessee, in 1952, Johnson spent much of his childhood outdoors, especially after his father took a job as a science writer in State College, Pennsylvania. Johnson's Boy Scout troop "didn't emphasize advancement, uniform, or ceremony," he says. "We just went." There were monthly backpacking trips regardless of the weather, and he remembers canoeing the Susquehanna one March during a snowstorm. Still an active outdoorsman fifty years later, Johnson recently completed a 200-mile backpacking trip along the John Muir Trail in California with his nephews.
During high school, Johnson, the son of two journalists, wrote for the school newspaper and the local paper, the Centre Daily Times. Later, when deciding on a career path, Johnson felt he had to choose between science and writing. "Little did I know that I would spend most of my time in science writing," he says. He is now working with his coauthors on the sixth edition of the iconic textbook Molecular Biology of the Cell.
In 1970, Johnson returned to Tennessee to attend Vanderbilt University in Nashville, alma mater of many of his family members. "I felt a real connection to that part of the South." He began as a physics and math major but switched to molecular biology, then a relatively new discipline, after a summer job as a laboratory technician at Penn State's Hershey Medical Center with physiologist Howard Morgan. "I tried to find a job in a physics or astronomy lab, but there were none available." He liked that "in biology one person with a good idea could actually do an important experiment." Johnson graduated with a BA in 1974, choosing to continue his studies in the nascent field in a PhD program.
The Switch That Started It All
After visiting a few of his top graduate school choices, Johnson found that he liked the atmosphere and students at Harvard University best. When he began his doctoral work on gene regulation, few systems existed to study the mechanism of how genes are turned on and off. In bacteriophage lambda, a virus that infects bacteria, sufficient genetic and biochemical work had been done to provide a rough outline of the process, and then-novel molecular tools, like restriction enzymes, for recombinant DNA technology made once-challenging experiments feasible. Johnson chose to work with Mark Ptashne in the biochemistry and molecular biology department because his laboratory was one of the few places where these tools were combined to study a transcription switch.
The lambda molecular switch determines whether the bacteriophage stays a prophage, coexisting with the host DNA, or enters the lytic phase during which it uses the host's machinery to make a multitude of new phages that lyse the cell. Ptashne had earlier shown that the lambda phage repressor, responsible for keeping lambda a prophage, worked by recognizing specific DNA sequences in the phage genome (2). Johnson began work on the Cro protein, which activates the lytic phase. He showed that the protein bound to the same three target sites on the phage DNA as the repressor, but in a different affinity order. This difference produced opposite gene expression patterns (3). Johnson also showed that proteins interact not only with the target DNA but also with each other. Lambda phage repressor binds cooperatively to DNA, attaching to the first site, which enhances the affinity of subsequent repressor dimers for the second site (4) . At the time, Johnson explains, binding cooperation was novel, although it is a wellestablished phenomenon now.
Effort put into experiments was matched by attention given to reporting the results under Ptashne's watch. "I never realized the work behind the scenes in good writing. The guy taught me that a paper could go through 25 drafts and the 26th draft could be a big improvement." Johnson continues to place emphasis on good writing, which he thinks is characterized by readability no matter how complicated the experiments. Johnson, who is often dismayed by the lack of good writing in science and bemoans the conflation of interpretation and speculation, strives to use plain language because "jargon can hide confused thinking." Herskowitz's laboratory at University of California at San Francisco (UCSF). For his first project, Johnson investigated how the regulator MATα2 controls genes. He first purified the protein and then tested the simplest possibility: that the protein worked by binding upstream of the target gene. The hypothesis proved correct, and, to confirm it, he swapped the regulator's target DNA sequence into another gene, bringing the gene under the control of MATα2 (5).
Johnson received a number of job offers but chose to stay at UCSF. His respect for the university outweighed the risk that colleagues would view him as an aging postdoctoral fellow. "I thought UCSF was the best place to do the kind of science I wanted to do." He continued to work on MATα2, which is a repressor, to determine exactly how it influenced gene expression. It bound far upstream of the target gene such that it was not blocking RNA polymerase as the lambda repressor had done. Using biochemical techniques, Johnson determined that, like the lambda repressor, MATα2 bound DNA cooperatively, this time with different proteins (6, 7) . "You can't get away from this stuff sometimes," he says and explains that we "now know that most transcriptional regulators work in combination."
Enter Candida By the 1990s, "We had answered a lot of the major questions I was interested in," he says, and "the field of transcriptional regulation was getting more and more crowded." Johnson decided to study a different yeast, C. albicans. "We thought we could use the knowledge and strategies developed for S. cerevisiae to study this medically important organism."
At the time, C. albicans had always been described as an asexual organism, but Johnson and his colleagues eventually discovered that, like S. cerevisiae, C. albicans has a mating cycle governed by a regulatory circuit known as white-opaque switching (8, 9) . As time went on, more work went into C. albicans and less into transcriptional regulation. In addition to the studies on mating regulators, Johnson's laboratory discovered circuits that allow C. albicans to proliferate in mammalian hosts, an ability most fungal species lack (10, 11) .
In his Inaugural Article, Johnson et al. investigate the structure of the DNA-binding domain in the "master regulator" of whiteopaque switching in C. albicans, Wor1. The protein, which consists of two conserved regions connected by a linker that varies in length and amino acid sequence, is found in many fungal species. Despite its evolutionary conservation and significant role, the protein's sequence was unlike any DNA binding motif Johnson and his colleagues had seen. They applied folding algorithms and sifted through structure databases. "We tried everything to find what it did," he says. The crystal structure finally revealed two β-pleated sheets clasped together and tilted in the major groove of DNA with additional interactions made by a flexible loop in the minor groove (1).
Coming Full Circuit C. albicans eventually led Johnson back to transcriptional regulation. In working out the mating regulators, Johnson looked for similarities to S. cerevisiae, which has three mating cell types. C. albicans, which shares a common ancestor with S. cerevisiae, has the same three cell types, but the regulatory circuit is different (12) . "This made no sense," Johnson says. "You would think something as fundamental as mating type regulation, which all yeasts do, would be conserved, but it wasn't." In the two hundred million years or so since the common ancestor, the destination had not changed, but the pathway had.
This realization about the molecular evolution of cell circuitry has fueled Johnson's work during the last five years. The bottom line, he says, is that "Transcriptional circuitry evolves very quickly." His original idea had been to use S. cerevisiae results to inform C. albicans work, but, Johnson explains, there A metaphorical depiction of the messiness of transcription circuits as products of evolution rather than design. "Selection acts on the output, not the machinery," says Johnson. Image courtesy of Nairi Hartooni and Trevor Sorrells.
is "almost no predictive value in gene regulation from S. cerevisiae to C. albicans." Typically, you find the "same protein, same DNA binding specificity, but different targets."
The most likely evolutionary scenario for this transcriptional rewiring suggests that the ancestral regulator coexists with a new regulator in a hybrid intermediate (13, 14) . "You don't break the circuit and make it again, because that's kind of no-no in evolution." Johnson says the concept drives home the point that there is no foresight in evolution because the new regulator isn't necessarily better. "A lot of really interesting things in biology happen non-adaptively," he explains. "That is not to say they won't be useful later on."
Johnson thinks that looking at the changes in complex circuitry over relatively short periods of evolutionary time will reveal further insight into how the circuitry evolves. "Transcriptional circuits in modern cells are messy because selection acts on the output, not the machinery." His team is designing computational programs to reconstruct extinct ancestral circuits and proteins in silico. For example, organisms like Candida dubliniensis, which diverged from C. albicans 10-20 million years ago, form distinct biofilms and have different infection profiles, making for good comparisons. The ability to design experiments to test ideas of evolution excites Johnson. "We can test hypotheses, and we can rule out models," he says. "Indeed, we have ruled out some of our favorite models."
